Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-31

Clinical Trial Update: Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females [NA]

View source ↗

Summary

Completed clinical trial comparing combination therapy of solifenacin and tadalafil versus solifenacin alone for overactive bladder in women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cialis (tadalafil)
  • Vesicare (solifenacin succinate)

Snippet

Sponsor: Ain Shams University | Conditions: Overactive Bladder | NA | Status: COMPLETED